C. Bolliger (Cape Town, South Africa), T. Scherer (Zurich, Switzerland)
The influence of emphysema heterogeneity on the magnitude of benefit following endoscopic thermal vapor ablation (InterVaporÔ) in patients with heterogeneous emphysema
F.J.F. Herth, A. Ernst, P. Hopkins, J.J. Egan, F. Stanzel, A. Valipour, M. Wagner, C. Witt, K. Baker, M.H. Gotfried, S. Kesten, G. Snell (Heidelberg, , Berlin, Germany; Boston, Iowa City, Phoenix, United States Of America; Chermside, Melbourne, Australia; Vienna, Austria)
|   |
Associations among one-year efficacy outcomes following endoscopic thermal vapor ablation (InterVaporÔ) for heterogeneous emphysema
P. Hopkins, F. J. F. Herth, G. Snell, K. Baker, C. Witt, M. H. Gotfried, A. Valipour, M. Wagner, F. Stanzel, J. J. Egan, S. Kesten, A. Ernst (Chermside, Melbourne, Australia; Berlin, Germany; Iowa City, Phoenix, Tustin, Boston, United States Of America; Vienna, Austria; Dublin, Ireland)
| |
The influence of baseline exercise tolerance on long-term efficacy outcomes following endoscopic thermal vapor ablation (InterVaporÔ) in patients with heterogeneous emphysema
A. Valipour, F.J.F. Herth, A. Ernst, P. Hopkins, J.J. Egan, F. Stanzel, M. Wagner, C. Witt, K. Baker, M.H. Gotfried, S. Kesten, G. Snell (Vienna, Austria; Heidelberg, , Berlin, Germany; Boston, Iowa City, Phoenix, Tustin, United States Of America; Chermside, Melbourne, Australia; Dublin, Ireland)
| |
Chartis evaluation of collateral ventilation versus HRCT assessment, in predicting clinical outcomes following endobronchial valve therapy (EBV) in COPD patients
S. Lindquist, S. Chung, M. Peters, A. Ing (Sydney, Australia)
| |
Pneumothorax as a predictor of beneficial outcome following endoscopic lung volume reduction
D. Gompelmann, R. Eberhardt, D.J. Slebos, J. Ficker, M. Wagner, B. Schmidt, L. Ek, F.J.F. Herth (Heidelberg, Halle, Germany; Groningen, Netherlands; , ; Lund, Sweden)
| |
Outcome of endobronchial valve (EBV) placement in lower lobes and in low heterogeneous patients
R. Eberhardt, D. Gompelmann, F.J.F. Herth, A. Valipour, A. Ernst, G.J. Criner, D.J. Slebos (Heidelberg, Germany; Vienna, Austria; Boston, Philadelphia, United States Of America; Groningen, Netherlands)
| |
Lung volume reduction coil treatment for patients with emphysema: 6-month multicenter feasibility results
G. Deslee, S. Blaas, W. Gesierich, F. Herth, J. Hetzel, M. Hetzel, R. Kessler, C.H. Marquette, M. Pfeifer, F. Stanzel, C. Witt, D.J. Slebos (Reims, , Nice, France; Gauting, Heidelberg, Tuebingen, Stuttgart, Hemer, Berlin, Germany; Groningen, Netherlands)
| |
Heterogeneous and homogenous emphysema both respond to lung volume reduction coil treatment
D.J. Slebos, S. Blaas, G. Deslee, W. Gesierich, F. Herth, J. Hetzel, M. Hetzel, R. Kessler, C.H. Marquette, M. Pfeifer, F. Stanzel, C. Witt (Groningen, Netherlands; , ; Reims, Strasbourg, Nice, France; Gauting, Heidelberg, Tuebingen, Stuttgart, Hemer, Berlin, Germany)
| |